What were Akums Drugs & Pharmaceuticals Ltd's latest quarterly results?
Akums Drugs & Pharmaceuticals Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +3.0%
- Revenue Growth YoY: +14.9%
- Operating Margin: 13.0%
Akums Drugs & Pharmaceuticals Ltd: Stock Analysis & Fundamentals
Updated this weekAkums Drugs & Pharmaceuticals Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 23.0. ROE: 17.2%. This stock is not currently in the Nifty 500 momentum outperformers list.
What's Happening
🌐FII stake decreased 5.1% this quarter
🏛️DII accumulation — stake up 1.7%
Key Numbers
Current Price
₹474
Market Cap
7.5K Cr
Valuation
N/AOther Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Akums Drugs & Pharmaceuticals Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Akums Drugs & Pharmaceuticals Ltd's current PE ratio?
Akums Drugs & Pharmaceuticals Ltd's current PE ratio is 23.0x.
- Current PE: 23.0x
- Market Cap: 7.5K Cr
What is Akums Drugs & Pharmaceuticals Ltd's price-to-book ratio?
Akums Drugs & Pharmaceuticals Ltd's price-to-book ratio is 2.4x.
- Price-to-Book (P/B): 2.4x
- Book Value per Share: ₹200
- Current Price: ₹474
Is Akums Drugs & Pharmaceuticals Ltd a fundamentally strong company?
Akums Drugs & Pharmaceuticals Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 16.0%
Is Akums Drugs & Pharmaceuticals Ltd debt free?
Akums Drugs & Pharmaceuticals Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹88 Cr
What is Akums Drugs & Pharmaceuticals Ltd's return on equity (ROE) and ROCE?
Akums Drugs & Pharmaceuticals Ltd's return ratios over recent years
- FY2023: ROCE 22.0%
- FY2024: ROCE 2.0%
- FY2025: ROCE 16.0%
Is Akums Drugs & Pharmaceuticals Ltd's cash flow positive?
Akums Drugs & Pharmaceuticals Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹465 Cr
- Free Cash Flow (FCF): ₹-83 Cr
- CFO/PAT Ratio: 135% (strong cash conversion)
What is Akums Drugs & Pharmaceuticals Ltd's dividend yield?
Akums Drugs & Pharmaceuticals Ltd currently does not pay a significant dividend (yield 0.00%).
- Dividend Yield: 0.00%
- Current Price: ₹474
Who holds Akums Drugs & Pharmaceuticals Ltd shares — promoters, FII, DII?
Akums Drugs & Pharmaceuticals Ltd's shareholding pattern (Dec 2025)
- Promoters: 75.3%
- FII (Foreign): 1.1%
- DII (Domestic): 14.4%
- Public: 6.5%
Is promoter holding increasing or decreasing in Akums Drugs & Pharmaceuticals Ltd?
Akums Drugs & Pharmaceuticals Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 75.3% (Dec 2025)
- Previous Quarter: 75.3% (Sep 2025)
- Change: 0.00% (stable)
Is Akums Drugs & Pharmaceuticals Ltd a new momentum entry or an established outperformer?
Akums Drugs & Pharmaceuticals Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Akums Drugs & Pharmaceuticals Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Akums Drugs & Pharmaceuticals Ltd may be worth studying
- Cash flow is positive — CFO ₹465 Cr
What is the investment thesis for Akums Drugs & Pharmaceuticals Ltd?
Akums Drugs & Pharmaceuticals Ltd investment thesis summary:
What is the future outlook for Akums Drugs & Pharmaceuticals Ltd?
Akums Drugs & Pharmaceuticals Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.